Open AccessEmerging Evidence for Neuropsycho-Consequences of COVID-19
Author(s) -
Jingwen Li,
Xi Liu,
Qing Zhang,
Xi Fang,
Fang Fang,
Xuefei Lv,
Dandan Zhang,
Yu Sun,
Na Li,
Shaoping Hu,
Zhicheng Lin,
Nian Xiong
Publication year - 2020
Publication title -
current neuropharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.955
H-Index - 73
eISSN - 1875-6190
pISSN - 1570-159X
DOI - 10.2174/1570159x18666200507085335
Subject(s) - myalgia , medicine , pandemic , public health , intensive care medicine , psychological intervention , disease , covid-19 , coronavirus , intervention (counseling) , respiratory system , psychiatry , immunology , pathology , infectious disease (medical specialty)
The pandemic novel coronavirus disease (COVID-19) has become a global concern in which the respiratory system is not the only one involved. Previous researches have presented the common clinical manifestations including respiratory symptoms (i.e., fever and cough), fatigue and myalgia. However, there is limited evidence for neurological and psychological influences of SARS-CoV-2. In this review, we discuss the common neurological manifestations of COVID-19 including acute cerebrovascular disease (i.e., cerebral hemorrhage) and muscle ache. Possible viral transmission to the nervous system may occur via circulation, an upper nasal transcribrial route and/or conjunctival route. Moreover, we cannot ignore the psychological influence on the public, medical staff and confirmed patients. Dealing with public psychological barriers and performing psychological crisis intervention are an important part of public health interventions.